232 related articles for article (PubMed ID: 24567069)
1. Proteomics and diabetic nephropathy: what have we learned from a decade of clinical proteomics studies?
Papale M; Di Paolo S; Vocino G; Rocchetti MT; Gesualdo L
J Nephrol; 2014 Jun; 27(3):221-8. PubMed ID: 24567069
[TBL] [Abstract][Full Text] [Related]
2. Identification of nephropathy predictors in urine from children with a recent diagnosis of type 1 diabetes.
Magagnotti C; Zerbini G; Fermo I; Carletti RM; Bonfanti R; Vallone F; Andolfo A
J Proteomics; 2019 Feb; 193():205-216. PubMed ID: 30366120
[TBL] [Abstract][Full Text] [Related]
3. Comparison of intrarenal renin-angiotensin system activity in diabetic versus non-diabetic patients with overt proteinuria.
Park JH; Jang HR; Lee JH; Lee JE; Huh W; Lee KB; Kwon YJ; Do JY; Kim HY; Kim YG
Nephrology (Carlton); 2015 Apr; 20(4):279-85. PubMed ID: 25522682
[TBL] [Abstract][Full Text] [Related]
4. Detection of autosomal dominant polycystic kidney disease by NMR spectroscopic fingerprinting of urine.
Gronwald W; Klein MS; Zeltner R; Schulze BD; Reinhold SW; Deutschmann M; Immervoll AK; Böger CA; Banas B; Eckardt KU; Oefner PJ
Kidney Int; 2011 Jun; 79(11):1244-53. PubMed ID: 21389975
[TBL] [Abstract][Full Text] [Related]
5. Insights into predicting diabetic nephropathy using urinary biomarkers.
Khan NU; Lin J; Liu X; Li H; Lu W; Zhong Z; Zhang H; Waqas M; Shen L
Biochim Biophys Acta Proteins Proteom; 2020 Oct; 1868(10):140475. PubMed ID: 32574766
[TBL] [Abstract][Full Text] [Related]
6. Urinary Proteomics for Diagnosis and Monitoring of Diabetic Nephropathy.
Currie G; Delles C
Curr Diab Rep; 2016 Nov; 16(11):104. PubMed ID: 27658932
[TBL] [Abstract][Full Text] [Related]
7. Proteomics and systems biology for understanding diabetic nephropathy.
Starkey JM; Tilton RG
J Cardiovasc Transl Res; 2012 Aug; 5(4):479-90. PubMed ID: 22581264
[TBL] [Abstract][Full Text] [Related]
8. Kidney tissue proteomics reveals regucalcin downregulation in response to diabetic nephropathy with reflection in urinary exosomes.
Zubiri I; Posada-Ayala M; Benito-Martin A; Maroto AS; Martin-Lorenzo M; Cannata-Ortiz P; de la Cuesta F; Gonzalez-Calero L; Barderas MG; Fernandez-Fernandez B; Ortiz A; Vivanco F; Alvarez-Llamas G
Transl Res; 2015 Nov; 166(5):474-484.e4. PubMed ID: 26072307
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological features of diabetic and nondiabetic renal diseases in type 2 diabetic patients with nephrotic-range proteinuria.
Lee YH; Kim KP; Kim YG; Moon JY; Jung SW; Park E; Kim JS; Jeong KH; Lee TW; Ihm CG; Jo YI; Choi HY; Park HC; Lee SY; Yang DH; Yi JH; Han SW; Lee SH
Medicine (Baltimore); 2017 Sep; 96(36):e8047. PubMed ID: 28885376
[TBL] [Abstract][Full Text] [Related]
10. The pathogenesis of diabetic nephropathy: focus on microRNAs and proteomics.
Conserva F; Pontrelli P; Accetturo M; Gesualdo L
J Nephrol; 2013; 26(5):811-20. PubMed ID: 23543479
[TBL] [Abstract][Full Text] [Related]
11. Aberrant cytokines/chemokines production correlate with proteinuria in patients with overt diabetic nephropathy.
Wu CC; Chen JS; Lu KC; Chen CC; Lin SH; Chu P; Sytwu HK; Lin YF
Clin Chim Acta; 2010 May; 411(9-10):700-4. PubMed ID: 20138168
[TBL] [Abstract][Full Text] [Related]
12. Proteomics and diabetic nephropathy.
Merchant ML; Klein JB
Curr Diab Rep; 2005 Dec; 5(6):464-9. PubMed ID: 16316599
[TBL] [Abstract][Full Text] [Related]
13. Urine miRNAs: potential biomarkers for monitoring progression of early stages of diabetic nephropathy.
Yang Y; Xiao L; Li J; Kanwar YS; Liu F; Sun L
Med Hypotheses; 2013 Aug; 81(2):274-8. PubMed ID: 23683774
[TBL] [Abstract][Full Text] [Related]
14. Proteomics and diabetic nephropathy.
Merchant ML; Klein JB
Semin Nephrol; 2007 Nov; 27(6):627-36. PubMed ID: 18061845
[TBL] [Abstract][Full Text] [Related]
15. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
Steinke JM; Mauer M;
Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of microscopic haematuria in diabetic nephropathy in type 2 diabetes patients with overt proteinuria.
Okada T; Nagao T; Matsumoto H; Nagaoka Y; Wada T; Nakao T
Nephrology (Carlton); 2013 Aug; 18(8):563-8. PubMed ID: 23714217
[TBL] [Abstract][Full Text] [Related]
17. Expression of cholecystokinin-1 receptor is correlated with proteinuria in human diabetic nephropathy.
Wang M; Xie R; Liu R; Jia X; Bao Y; Liu X
Endocrine; 2012 Oct; 42(2):329-34. PubMed ID: 22396142
[TBL] [Abstract][Full Text] [Related]
18. Study of diabetic nephropathy in the proteomic era.
Thongboonkerd V
Contrib Nephrol; 2011; 170():172-183. PubMed ID: 21659770
[TBL] [Abstract][Full Text] [Related]
19. Proteomic discovery of diabetic nephropathy biomarkers.
Merchant ML; Klein JB
Adv Chronic Kidney Dis; 2010 Nov; 17(6):480-6. PubMed ID: 21044770
[TBL] [Abstract][Full Text] [Related]
20. New insights into the use of biomarkers of diabetic nephropathy.
Jha JC; Jandeleit-Dahm KA; Cooper ME
Adv Chronic Kidney Dis; 2014 May; 21(3):318-26. PubMed ID: 24780461
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
